Smarter trials, better patient outcomes
Oncology and hematology drug development present an array of operational challenges to sponsors. Patient access is difficult, competition is high and the right sites are mission critical to deliver defined patient subsets to enroll with planned timelines.
Effective clinical development requires precision solutions for an increasingly complex and rapidly evolving treatment paradigm landscape.
Parexel is partnering with Paradigm Health to combine our global clinical operations regulatory and therapeutic expertise with their AI-driven patient matching, site intelligence and EHR-to-EDC eSource capabilities – for a future-ready operating model. The result for sponsors is faster enrollment, cleaner data and shorter time to critical milestones.
Together, we drive better results at every stage
Study planning, protocol design and feasibility
Data-driven and qualitative insights from patients, biostatistics and clinical operations experts optimize protocols with fit-for-purpose design that incorporate the voice of the patient while avoiding costly amendments and unnecessary burden.
Start-up
Deep visibility into site capabilities and active patient populations drives informed site selection and faster activation.
Enrollment
AI-enabled patient identification within a therapeutically focused network of sites is a faster, more effective approach to patient recruitment and enrollment.
Conduct – Database Lock
Unlock the value of direct data capture with reduced monitoring resources, source data verification (SDV) requirements and significantly improved data quality.
Better Together
